FDA Charts Transparency Plans | GenomeWeb

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Food and Drug Administration has issued a report detailing its plans to enhance the agency’s transparency and communications efforts to the industries it regulates, which include the recent launch of a website to provide companies with submission and regulatory information, and it is seeking public comments on some of these plans.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.